Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05390398 | Study on Fatigue in Colorectal Cancer Survivors, a Lifestyle Intervention(SoFiT) | completed | N/A | 161 | Wageningen UniversityOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT06900686 | Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival | completed | — | 458 | Yanhong DengOTHER | 0 | Mar 28, 2025 | clinicaltrials |
| NCT03506321 | Comparison of the Benefit of Chromoendoscopy in Addition to High Definition White Light and Narrow Band Imaging for the Prediction of Submucosal Invasive Cancer in Colonic Lesions(LANS) | completed | N/A | 400 | Western Sydney Local Health DistrictOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT04138030 | Conventional Endoscopic Mucosal Resection Versus Cold Snare Endoscopic Mucosal Resection of Colonic Lateral Spreading Lesions - A Randomised Controlled Trial | completed | N/A | 182 | Western Sydney Local Health DistrictOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT06898359 | Role of Gut Microbiota in Neoadjuvant Radioimmunotherapy for MSS, Locally Advanced Rectal Cancer | completed | — | 29 | Yanhong DengOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT00059930 | Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer | completed | Phase 1 | 38 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT02895464 | Feasibility of Home-based Preoperative Exercise in Older People | completed | N/A | 23 | Karolinska InstitutetOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT03724851 | Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer | completed | Phase 1 / Phase 2 | 120 | MedPacto, Inc.INDUSTRY | 1 | Mar 25, 2025 | clinicaltrials |
| NCT03195699 | Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers | completed | Phase 1 | 64 | Tvardi Therapeutics, IncorporatedINDUSTRY | 1 | Mar 21, 2025 | clinicaltrials |
| NCT00200200 | Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer | completed | Phase 2 | 73 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT00545545 | Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma | completed | Phase 1 / Phase 2 | 32 | HiberCell, Inc.INDUSTRY | 1 | Mar 19, 2025 | clinicaltrials |
| NCT02649790 | Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications | completed | Phase 1 / Phase 2 | 277 | Karyopharm Therapeutics IncINDUSTRY | 5 | Mar 19, 2025 | clinicaltrials |
| NCT04256707 | Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment(SPRINT) | completed | Phase 1 / Phase 2 | 126 | Karyopharm Therapeutics IncINDUSTRY | 1 | Mar 19, 2025 | clinicaltrials |
| NCT00906997 | Colorectal Cancer Screening in Average-risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy | completed | N/A | 55,498 | Hospital Clinic of BarcelonaOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT05943288 | Safety and Efficacy of the Olympus CADe System in Real-time Colonoscopy(EuroCADe) | completed | — | 850 | Olympus Europe SE & Co. KGINDUSTRY | 4 | Mar 18, 2025 | clinicaltrials |
| NCT04072198 | Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients(NIVACOR) | completed | Phase 2 | 73 | Gruppo Oncologico Italiano di Ricerca ClinicaOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT04636619 | Clinical Trial Evaluating External Evaluation and Training on the Incomplete Resection (POLIPEVA Study)(POLIPEVA) | completed | N/A | 1,920 | Hospital del Rio HortegaOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT05402592 | The Effect of Oral Carbohydrate Administration on Postoperative Well-being | completed | N/A | 50 | Muğla Sıtkı Koçman UniversityOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT06865586 | A Comparative Study of Tumor Specific Mesocolic Excision and Complete Mesocolic Excision for Right Sided Colon Cancer : Asian Multicenter Retrospective Study | completed | — | 3,326 | Asan Medical CenterOTHER | 1 | Mar 10, 2025 | clinicaltrials |
| NCT03761017 | MGD019 DART® Protein in Unresectable/Metastatic Cancer | completed | Phase 1 | 162 | MacroGenicsINDUSTRY | 5 | Mar 6, 2025 | clinicaltrials |
| NCT05697198 | PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine(PREFER) | completed | — | 1,429 | Labcorp Corporation of America Holdings, IncINDUSTRY | 1 | Mar 6, 2025 | clinicaltrials |
| NCT05740137 | Adenoma Detection Rate in Artificial Intelligence-assisted Colonoscopy | completed | N/A | 795 | Ismail GögenurOTHER | 1 | Mar 6, 2025 | clinicaltrials |
| NCT03829410 | Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a KRAS Mutation | completed | Phase 1 / Phase 2 | 68 | Cardiff OncologyINDUSTRY | 1 | Mar 4, 2025 | clinicaltrials |
| NCT01226979 | Study of High-Dose-Rate Endorectal Brachytherapy (HDRBT) in the Treatment of Locally Advanced Low Rectal Cancer(HDRBT) | completed | N/A | 16 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT03396926 | Pembrolizumab, Capecitabine, and Bevacizumab for Treating Colorectal Cancer | completed | Phase 2 | 44 | University of California, San FranciscoOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT03058289 | A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6(IT-01) | completed | Phase 1 / Phase 2 | 111 | Intensity Therapeutics, Inc.INDUSTRY | 2 | Feb 27, 2025 | clinicaltrials |
| NCT06168825 | Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention(MOM) | completed | — | 40 | Inova Health Care ServicesOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT05131815 | The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors | completed | N/A | 8 | Cedars-Sinai Medical CenterOTHER | 1 | Feb 26, 2025 | clinicaltrials |
| NCT06029010 | An Observational Study to Learn More About the Long-Term Responses to Treatment With Regorafenib in Patients With Metastatic Colorectal Cancer in the United States(COLONGER) | completed | — | 2,326 | BayerINDUSTRY | 1 | Feb 26, 2025 | clinicaltrials |
| NCT01643070 | Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases | completed | Phase 2 | 38 | Asan Medical CenterOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT04380337 | Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer | completed | Phase 2 | 38 | Stanford UniversityOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT04947020 | DataBase for Analysis of Rectal Cancer Oncological Results(BARO) | completed | — | 2,443 | Jagiellonian UniversityOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT05512793 | Clinical Validation of PolyDeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System. Polydeep Advance 2. | completed | N/A | 260 | Fundacin Biomedica Galicia SurOTHER | 1 | Feb 24, 2025 | clinicaltrials |
| NCT05513261 | Clinical Validation of PolyDeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System. Polydeep Advance 3 | completed | N/A | 857 | Fundacin Biomedica Galicia SurOTHER | 1 | Feb 24, 2025 | clinicaltrials |
| NCT05514301 | Clinical Validation of Polydeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System | completed | N/A | 205 | Fundacin Biomedica Galicia SurOTHER | 1 | Feb 24, 2025 | clinicaltrials |
| NCT06233253 | Online Mindfulness-Based Intervention to Decrease Pre-Procedural Anxiety Before a First-Time Screening Colonoscopy | completed | N/A | 100 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Feb 24, 2025 | clinicaltrials |
| NCT06839508 | Comprehensive Management of Rectal Cancer(CMRC) | completed | — | 8 | Centre Hospitalier de Saint-DenisOTHER | 1 | Feb 24, 2025 | clinicaltrials |
| NCT06707337 | Brief Self-Compassion Program in Colorectal Cancer | completed | N/A | 66 | Kübra DAKDEVİROTHER_GOV | 1 | Feb 21, 2025 | clinicaltrials |
| NCT05920980 | Effect of Lidocaine on Postoperative Pain in Elderlypatients Undergoing Colorectal Cancer Surgery | completed | N/A | 276 | West China HospitalOTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT05227261 | Early Detection of Five Common Cancers Using the ctDNA Analysing Test(K-DETEK) | completed | — | 9,057 | Gene SolutionsINDUSTRY | 1 | Feb 18, 2025 | clinicaltrials |
| NCT03190174 | Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers | completed | Phase 1 / Phase 2 | 34 | Sarcoma Oncology Research Center, LLCOTHER | 1 | Feb 17, 2025 | clinicaltrials |
| NCT05445245 | The Longitudinal Study of Low Anterior Resection Syndrome in Patients with Newly Diagnosed Rectal Cancer. | completed | — | 125 | Chang Gung Memorial HospitalOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT05943041 | Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer | completed | Phase 1 | 9 | GILongevityINDUSTRY | 1 | Feb 14, 2025 | clinicaltrials |
| NCT03992664 | Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment. | completed | N/A | 40 | Cyprus University of TechnologyOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT03574493 | Rectal Surgery Evaluation Trial (RESET)(RESET) | completed | — | 1,098 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04015804 | Robotic Low Rectum Anterior Resection(GROG-R01) | completed | N/A | 833 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 3 | Feb 12, 2025 | clinicaltrials |
| NCT04186117 | Development of Clinical and Biological Database in Colorectal Cancer(CIRCUS) | completed | N/A | 89 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04666688 | LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 / Phase 2 | 44 | PureTechINDUSTRY | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04696757 | Non-OpeRative MANagement of Rectal Cancer Patients(NORMANDY) | completed | Phase 2 | 18 | Kangbuk Samsung HospitalOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT05472753 | Dietary Supplement on the Intestinal Microbiota in Patients with Colon Cancer(TERATROFO) | completed | N/A | 75 | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludOTHER | 1 | Feb 12, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Mar 28, 2025source: clinicaltrials